Pyrimidine inhibitors of ERK protein kinase and uses therof

Details for Australian Patent Application No. 2005316599 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Martinez-Botella, Gabriel; Maltais, Francois; Tang, Qing; Aronov, Alex; Hale, Michael R.; Straub, Judith

Agent Cullen & Co

Pub. Number AU-A-2005316599

PCT Pub. Number WO2006/065820

Priority 60/636,167 14.12.04 US

Filing date 13 December 2005

Wipo publication date 22 June 2006

International Classifications

C07D 239/30 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/065820 Priority application(s): WO2006/065820

17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005316610-Lighting ballast having boost converter with on/off control and method of ballast operation

2005316597-Bodily fluid space entry detection